Work

Abstract 3916: A potent CDK7 inhibitor TY-2699a has the potential for combination with chemotherapy or immunotherapy in solid tumors.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3916

Authors: Shengli Dong, Apeng Liang, Zhengfei Guo, Zhiyong He, Meihua Li, Xinlong Yang, Chao Zhou, Yu Yu, Hongqiang Li, Jian Zhu, Chengshan Niu, Shaoqing Chen, Jun Li, Yusheng Wu

Institution: TYK Medicines, Inc.

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148804356

Cites:

Cited by:

Related to: